Investors have plowed another $130 million into a Series B to back the startup that’s led by Genentech vets, which brings its total raised to almost $350…

In our EuroBiotech roundup this week, Clal benefits from Pfizer-Medivation deal, Hansa posts Phase II data, NeuroVive jettisons COO and more.

BioLineRx has teamed up with I-Bridge Capital to set up a Chinese drug development joint venture, iPharma.

The late-stage skin condition biotech Novan is looking to batter ongoing headwinds and gun for a $60 million public offering.

The FDA has slapped a complete response letter onto Amgen for its experimental med to treat a hormonal imbalance in dialysis patients, dashing its hopes of a…

Just two months after signing a CAR-T deal with Baylor, London-based Cell Medica has penned a new pact with University College London (UCL) to use its T-cell…

Promethera Biosciences is planning to IPO in April or May to raise €40 million for its pipeline of liver cell therapies.

Pfizer, $14 billion down after its biotech bonanza buyout of Medivation in cash this week, still has money in the pot to buy AstraZeneca’s antibiotics unit.